Pasqal, a French quantum-computing startup, plans to go public on the Nasdaq through a merger with the blank-check company Bleichroeder.

The move signals a push to transition quantum technology from experimental research into commercial viability. By securing public capital, the Paris-based firm aims to accelerate the deployment of its specialized neutral-atom hardware for industrial use.

The company is targeting a valuation of $2 billion [1] for the SPAC merger. This financial transition is expected to conclude in the second half of 2026 [2]. Pasqal specializes in neutral-atom technology, a method of quantum computing that differs from the superconducting loops used by some other industry leaders.

Raising capital through the U.S. markets allows the firm to scale its operations and expand its reach. The company intends to use the funds to accelerate the commercialization of its technology [3]. This strategy comes as the global race for quantum supremacy intensifies among national governments and private corporations.

Pasqal has recently gained visibility in the competitive landscape. The company was selected as a finalist in the XPRIZE Quantum Applications competition on May 11, 2026 [4]. This recognition underscores the technical progress the firm has made in applying quantum logic to real-world problems.

The merger with Bleichroeder provides a faster route to the public market than a traditional initial public offering. By utilizing a special purpose acquisition company, Pasqal can bypass some of the standard IPO timelines while gaining immediate access to the Nasdaq exchange [5].

Pasqal plans to go public on the Nasdaq through a merger with the blank-check company Bleichroeder.

Pasqal's move to the Nasdaq via a SPAC suggests that quantum computing startups are seeking the liquidity and visibility of U.S. capital markets to fund the high costs of hardware scaling. A $2 billion valuation for a neutral-atom specialist indicates strong investor confidence in this specific technical approach over competing modalities, potentially shifting the industry's center of gravity toward European innovation funded by American equity.